Clinical Trial: A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07845487) titled 'A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis' on Sept. 21.

Brief Summary: The ASCENTRA-UC study is a phase 2 study testing PALI-2108 in patients with moderate to severe ulcerative colitis. Doses of drug will be compared against a placebo to see how well it works, how safe it is, and how the body responds to it.

Study Start Date: Aug. 28

Study Type: INTERVENTIONAL

Condition: Ulcerative Colitis (UC) Severe Ulcerative Colitis Moderate Ulcerative Colitis

Intervention: DRUG: PALI-2108

Oral Dose

DRUG: PALI-2108

Oral Dose

DRUG: Placebo

Oral Dose

Recruitme...